Royalty Pharma plc (RPRX) Tops Q2 Revenue Estimate

Go back to Royalty Pharma plc (RPRX) Tops Q2 Revenue Estimate
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 53.57 --0 (-0%)
Previous Close $53.57    52 Week High $3.48 
Open $53.57    52 Week Low $0.80 
Day High $53.57    P/E N/A 
Day Low $53.57    EPS $-1.54 
Volume 400